Preclinical murine models to study lung infection with Mycobacterium abscessus complex
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preclinical murine models to study lung infection with Mycobacterium abscessus complex
Authors
Keywords
-
Journal
TUBERCULOSIS
Volume 138, Issue -, Pages 102301
Publisher
Elsevier BV
Online
2022-12-30
DOI
10.1016/j.tube.2022.102301
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic efficacy of antimalarial drugs targeting DosRS signaling in Mycobacterium abscessus
- (2022) Juan Manuel Belardinelli et al. Science Translational Medicine
- Combined Host- and Pathogen-Directed Therapy for the Control of Mycobacterium abscessus Infection
- (2022) Noemi Poerio et al. Microbiology Spectrum
- The aminoglycoside modifying enzyme Eis2 represents a new potentialin vivotarget for reducing antimicrobial drug resistance inMycobacterium abscessuscomplex
- (2022) Nicola Ivan Lorè et al. EUROPEAN RESPIRATORY JOURNAL
- Alternatives to Antibiotics against Mycobacterium abscessus
- (2022) Antonio Broncano-Lavado et al. Antibiotics-Basel
- Clofazimine as a comparator for preclinical efficacy evaluations of experimental therapeutics against pulmonary M. abscessus infection in mice
- (2022) Divya Sriram et al. TUBERCULOSIS
- A Leucyl-tRNA Synthetase Inhibitor with Broad-Spectrum Anti-Mycobacterial Activity
- (2021) Uday S. Ganapathy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Stepwise pathogenic evolution of Mycobacterium abscessus
- (2021) Josephine M. Bryant et al. SCIENCE
- Treatment of Mycobacterium abscessus Pulmonary Disease
- (2021) David E. Griffith et al. CHEST
- Dissemination of Mycobacterium abscessus via global transmission networks
- (2021) Christopher Ruis et al. Nature Microbiology
- Potency of Omadacycline against Mycobacteroides abscessus Clinical Isolates In Vitro and in a Mouse Model of Pulmonary Infection
- (2021) Danielle A. Nicklas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of epetraborole against Mycobacterium abscessus is increased with norvaline
- (2021) Jaryd R. Sullivan et al. PLoS Pathogens
- Type I Interferons Are Involved in the Intracellular Growth Control of Mycobacterium abscessus by Mediating NOD2-Induced Production of Nitric Oxide in Macrophages
- (2021) Jae-Hun Ahn et al. Frontiers in Immunology
- Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus
- (2020) Matt D. Johansen et al. NATURE REVIEWS MICROBIOLOGY
- A mouse model of pulmonary Mycobacteroides abscessus infection
- (2020) Emily C. Maggioncalda et al. Scientific Reports
- Efficacy of Bedaquiline, Alone or in Combination with Imipenem, against Mycobacterium abscessus in C3HeB/FeJ Mice
- (2020) Vincent Le Moigne et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Peroxisome Proliferator-Activated Receptor α- Agonist Gemfibrozil Promotes Defense Against Mycobacterium abscessus Infections
- (2020) Yi Sak Kim et al. Cells
- Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline
- (2020) Charles L. Daley et al. EUROPEAN RESPIRATORY JOURNAL
- Preclinical Models of Nontuberculous Mycobacteria Infection for Early Drug Discovery and Vaccine Research
- (2020) Elisa Rampacci et al. Pathogens
- Alternative and Experimental Therapies of Mycobacterium abscessus Infections
- (2020) Michal Meir et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A New Model of Chronic Mycobacterium abscessus Lung Infection in Immunocompetent Mice
- (2020) Camilla Riva et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A TLR2-Activating Fraction From Mycobacterium abscessus Rough Variant Demonstrates Vaccine and Diagnostic Potential
- (2020) Vincent Le Moigne et al. Frontiers in Cellular and Infection Microbiology
- Indole-2-carboxamides are Active Against an Acute Mycobacterium abscessus Infected Mouse Model
- (2019) Amit N. Pandya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- First time in human (FTIH) study and prediction of early bactericidal activity for GSK3036656, a potent Leucyl - tRNA synthetase inhibitor for tuberculosis treatment
- (2019) David Tenero et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clofazimine inhalation suspension for the aerosol treatment of pulmonary nontuberculous mycobacterial infections
- (2019) Brandon Banaschewski et al. Journal of Cystic Fibrosis
- Bedaquiline Eliminates Bactericidal Activity of β-Lactams against Mycobacterium abscessus
- (2019) Marissa Lindman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rifabutin is active against Mycobacterium abscessus in mice
- (2019) Thomas Dick et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mycobacterium abscessus—Bronchial Epithelial Cells Cross-Talk Through Type I Interferon Signaling
- (2019) Chongxu Zhang et al. Frontiers in Immunology
- Treatment outcomes of rifabutin-containing regimens for rifabutin-sensitive multidrug-resistant pulmonary tuberculosis
- (2017) Hyun Lee et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656)
- (2017) Xianfeng Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Nucleotide-Binding Oligomerization Domain 2 Contributes to Limiting Growth of Mycobacterium abscessus in the Lung of Mice by Regulating Cytokines and Nitric Oxide Production
- (2017) Jun-Young Lee et al. Frontiers in Immunology
- Susceptibility of Mycobacterium abscessus to Antimycobacterial Drugs in Preclinical Models
- (2015) Andrés Obregón-Henao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mycobacterium abscessus Morphotype Comparison in a Murine Model
- (2015) Lindsay J. Caverly et al. PLoS One
- US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
- (2015) R Andres Floto et al. THORAX
- Bacterial phospholipases C as vaccine candidate antigens against cystic fibrosis respiratory pathogens: The Mycobacterium abscessus model
- (2015) Vincent Le Moigne et al. VACCINE
- In VivoAssessment of Drug Efficacy against Mycobacterium abscessus Using the Embryonic Zebrafish Test System
- (2014) Audrey Bernut et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro activity of cefoxitin and imipenem against Mycobacterium abscessus complex
- (2013) M. Lavollay et al. CLINICAL MICROBIOLOGY AND INFECTION
- GM-CSF knockout mice for preclinical testing of agents with antimicrobial activity against Mycobacterium abscessus
- (2013) M. A. De Groote et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In Vivo Evaluation of Antibiotic Activity Against Mycobacterium abscessus
- (2013) Isabelle Lerat et al. JOURNAL OF INFECTIOUS DISEASES
- Design, Synthesis, and Biological Evaluation of Indole-2-carboxamides: A Promising Class of Antituberculosis Agents
- (2013) Ravinder Reddy Kondreddi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification and characterization of the genetic changes responsible for the characteristic smooth-to-rough morphotype alterations of clinically persistentMycobacterium abscessus
- (2013) Alexandre Pawlik et al. MOLECULAR MICROBIOLOGY
- Indolcarboxamide Is a Preclinical Candidate for Treating Multidrug-Resistant Tuberculosis
- (2013) S. P. S. Rao et al. Science Translational Medicine
- Indoleamides are active against drug-resistant Mycobacterium tuberculosis
- (2013) Shichun Lun et al. Nature Communications
- Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria
- (2012) Jakko van Ingen et al. DRUG RESISTANCE UPDATES
- Mycobacterium abscessus: a new antibiotic nightmare
- (2012) R. Nessar et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Host Immune Response to Rapidly Growing Mycobacteria, an Emerging Cause of Chronic Lung Disease
- (2010) Edward D. Chan et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Overexpression of proinflammatory TLR-2-signalling lipoproteins in hypervirulent mycobacterial variants
- (2010) Anne-Laure Roux et al. CELLULAR MICROBIOLOGY
- Mycobacterium abscessusactivates the macrophage innate immune response via a physical and functional interaction between TLR2 and dectin-1
- (2008) Dong-Min Shin et al. CELLULAR MICROBIOLOGY
- Animal model of Mycobacterium abscessus lung infection
- (2008) D. Ordway et al. JOURNAL OF LEUKOCYTE BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started